Special Issue "Drug Treatments for Inflammatory Bowel Diseases"

Pharmaceuticals (Basel). 2023 Dec 29;17(1):59. doi: 10.3390/ph17010059.

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic idiopathic, relapsing and remitting inflammatory diseases that affect the gastrointestinal tract, causing significant morbidity and loss of quality of life in affected individuals [...].

Publication types

  • Editorial

Grants and funding

This research received no external funding.